Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma
Clinical trial NCT00466687 · COMPLETED
Trial details
- NCT number
- NCT00466687
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2008-08-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.